Cargando…

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

INTRODUCTION: Primary Sjögren’s syndrome (pSS) is an autoimmune disorder affecting exocrine glands; however, a subgroup of pSS patients experience systemic extra-glandular involvement leading to a worsening of disease prognosis. Current therapeutic options are mainly empiric and often translated by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carubbi, Francesco, Cipriani, Paola, Marrelli, Alessandra, Benedetto, Paola Di, Ruscitti, Piero, Berardicurti, Onorina, Pantano, Ilenia, Liakouli, Vasiliki, Alvaro, Saverio, Alunno, Alessia, Manzo, Antonio, Ciccia, Francesco, Gerli, Roberto, Triolo, Giovanni, Giacomelli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979092/ https://www.ncbi.nlm.nih.gov/pubmed/24286296 http://dx.doi.org/10.1186/ar4359

Ejemplares similares

Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis
por: Cipriani, Paola, et al.
Publicado: (2016)

Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities
por: Ruscitti, Piero, et al.
Publicado: (2018)

Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis
por: Cipriani, Paola, et al.
Publicado: (2014)

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy
por: Di Benedetto, Paola, et al.
Publicado: (2018)

Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts
por: Liakouli, Vasiliki, et al.
Publicado: (2019)

Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers
por: Ruscitti, Piero, et al.
Publicado: (2016)

The Role of IL-1β in the Bone Loss during Rheumatic Diseases
por: Ruscitti, Piero, et al.
Publicado: (2015)

Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
por: Ruscitti, Piero, et al.
Publicado: (2017)

Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features
por: Cipriani, Paola, et al.
Publicado: (2014)

Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
por: Ruscitti, Piero, et al.
Publicado: (2017)

IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study
por: Ruscitti, Piero, et al.
Publicado: (2019)

Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren’s syndrome minor salivary glands
por: Carubbi, Francesco, et al.
Publicado: (2019)

Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts
por: Cipriani, Paola, et al.
Publicado: (2015)

Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature
por: Ruscitti, Piero, et al.
Publicado: (2015)

Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling
por: Di Benedetto, Paola, et al.
Publicado: (2019)

Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
por: Ruscitti, Piero, et al.
Publicado: (2020)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
por: Di Benedetto, Paola, et al.
Publicado: (2020)

Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6
por: Ruscitti, Piero, et al.
Publicado: (2022)

Lymphoma and Lymphomagenesis in Primary Sjögren’s Syndrome
por: Alunno, Alessia, et al.
Publicado: (2018)

T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives
por: Alunno, Alessia, et al.
Publicado: (2015)

Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome
por: Cafaro, Giacomo, et al.
Publicado: (2021)

Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
por: Ruscitti, Piero, et al.
Publicado: (2020)

Association Between Minor Salivary Gland Biopsy During Sjӧgren’s Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis
por: Berardicurti, Onorina, et al.
Publicado: (2021)

Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences
por: Ruscitti, Piero, et al.
Publicado: (2020)

The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience
por: Carubbi, Francesco, et al.
Publicado: (2020)

Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
por: Ruscitti, Piero, et al.
Publicado: (2020)

Incidence of venous thromboembolism in rheumatoid arthritis, results from a “real-life” cohort and an appraisal of available literature
por: Conforti, Alessandro, et al.
Publicado: (2021)

Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis
por: Alunno, Alessia, et al.
Publicado: (2017)

Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets
por: Alunno, Alessia, et al.
Publicado: (2017)

Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis
por: Carubbi, Francesco, et al.
Publicado: (2019)

Cytokine storm syndrome in severe COVID-19
por: Ruscitti, Piero, et al.
Publicado: (2020)

Interferon gamma-inducible protein 16 in primary Sjögren’s syndrome: a novel player in disease pathogenesis?
por: Alunno, Alessia, et al.
Publicado: (2015)

Rheumatic manifestations of COVID-19: a systematic review and meta-analysis
por: Ciaffi, Jacopo, et al.
Publicado: (2020)

Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort
por: Di Benedetto, Paola, et al.
Publicado: (2020)

Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
por: Di Benedetto, Paola, et al.
Publicado: (2021)

The Impact of Fibromyalgia in Spondyloarthritis: From Classification Criteria to Outcome Measures
por: Alunno, Alessia, et al.
Publicado: (2018)

Comparison of Rituximab Originator With CT-P10 Biosimilar in Patients With Primary Sjögren's Syndrome: A Retrospective Analysis in a Real-Life Setting
por: Pavlych, Viktoriya, et al.
Publicado: (2020)

Editorial: Management of Sjögren's Syndrome
por: Alunno, Alessia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hdgckr43n2dfhrr94esmjhleh3